Research Results
Beta Version
Use the search bar below to find studies, or apply one or more filters to narrow your results. See our list of keywords to guide your search.
Search by keyword
Select
Select
- All Risk Factors
- Air Pollution
- Alcohol
- Antimicrobials
- Artificial sweeteners
- Bisphenols
- Body Weight
- Breast Density
- Chemical Mixtures
- Chemicals in products
- Cleaning Products
- Diet
- Exercise
- Family History
- Furniture & Electronics
- Genetics
- Gut Health
- Hair Dye
- Hormones
- Inflammation
- Job
- Light at night
- Metals
- Neighborhood
- Night Shift Work
- Noise
- Non-stick Pans & Waterproof Gear
- Oral Contraceptives
- PAHs
- Parabens
- PCBs
- Personal Care Products
- Pesticides
- PFAS
- Pharmaceuticals
- Place-based
- Plastic
- Pregnancy & Breastfeeding
- Processed Food
- Puberty Age
- Race/Ethnicity
- Radiation
- Red meat
- Scented Products & Soft Plastic
- Sleeping Patterns
- Soda
- Stress
- Sugar
- Sunscreen
- Tobacco
- Vitamin D
Select
Select
Select
Select
Select the Chemical Agents
- All Chemical Agents
- 1,1,2,2-TCA
- 1,3-Butadiene
- Acrolein
- Aldrin
- Alkylphenols
- Antimicrobials
- Antimicrobials: QACs, Triclosan, Triclocarban
- Aromatic Amines
- Arsenic
- Artificial Sweeteners
- Atrazine
- Benzene
- Bisphenols
- Cadmium
- Chlordane
- Chlorpyrifos
- DDT
- Dibutyl Phthalate
- Dichlorvos
- Dieldrin
- Dioxins
- ell/
- Ethanol (alcohol)
- Ethyl Benzene
- Ethylene Oxide
- Flame Retardants
- Food
- Formaldehyde
- Glyphosate
- Heptachlor
- Hormones
- Insulin
- Lead
- Light at Night
- Mercury
- Metals
- Methoxyclor
- Naphthalene
- Night Shift Work
- Nitrogen Dioxide
- Noise
- Oral Contraceptives
- Organochlorine Pesticides
- Organophosphate Pesticides
- Ozone
- PAHs
- Parabens
- Particulate Matter
- PCBs
- Pesticides
- PFAS
- Phenols
- Phthalates
- Processed Food
- PVC
- Radiation: Ionizing
- Radiation: Non-Ionizing
- Soda
- Stress
- Sugar
- Tobacco
- Toluene
- Trichloroethylene
- Triclosan
- Ultraviolet Radiation
- UV Filters
- Vinyl Chloride
Select the Study Tags
Sort By
- Relevance
- Title (A to Z)
- Title (Z to A)
- Publication Year (Ascending)
- Publication Year (Descending)
- Authors (A to Z)
- Authors (Z to A)
2022
Environ Int
A study of 48,450 women followed for over 10 years found that higher residential UV radiation exposure was associated with a 27% reduced risk of estrogen receptor-negative (ER-) breast cancer, but showed no association with overall breast cancer risk or ER-positive breast cancer. The protective effect against ER- breast cancer was particularly strong (48% risk reduction) among women who did not regularly take Vitamin D supplements, while those taking supplements showed no benefit from UV exposure. These findings suggest that UV-induced Vitamin D production may specifically protect against ER- breast cancer, a particularly aggressive subtype, supporting the importance of adequate Vitamin D levels through natural sunlight exposure or supplementation.
2019
Am J Clin Nutr
A large French cohort study of 76,442 women over age 50 followed for 11 years found that current soy supplement use was associated with a 22% reduced risk of estrogen receptor-positive (ER+) breast cancer but a 101% increased risk of ER-negative breast cancer compared to never users. The risk profile varied significantly by personal characteristics: women with a family history of breast cancer showed a 36% increased risk with soy supplement use, while those without family history showed an 18% reduced risk; premenopausal or recently postmenopausal women showed a 50% risk reduction, while women more than 5 years past menopause showed a 6% increased risk. These findings suggest that soy supplements—often marketed as natural alternatives to hormone therapy—may have complex and opposing effects on breast cancer risk depending on tumor biology and individual characteristics, cautioning against their use particularly in women with breast cancer family history.
2024
Cancer Med
A mouse study found that exposure to bacterial toxins (lipopolysaccharides or LPS) during puberty—a critical period for breast development—caused lasting inflammation and changes in gene expression that increased breast cancer risk later in life. Researchers discovered that a prebiotic supplement derived from shiitake mushrooms (AHCC) could counteract these harmful effects by reducing inflammation, regulating immune signaling molecules, and blocking cancer-promoting gene activity in mammary tissue. The findings suggest that gut health and inflammation during puberty may influence long-term breast cancer risk, and that dietary interventions like prebiotics might offer a preventive strategy, though human studies are needed to confirm these results.
2023
Frontiers
A meta-analysis of 21 studies including 734,372 participants worldwide found that light at night (LAN) exposure was associated with a 12% increased breast cancer risk overall, with case-control studies showing 16% increased risk and cohort studies showing 8% increased risk. The association was particularly pronounced in Asian populations (24% increased risk) and for ER-positive breast cancers (10% increased risk), while outdoor LAN specifically showed a 7% increased risk. These findings support the hypothesis that artificial light exposure at night disrupts circadian rhythms and suppresses melatonin production—a hormone with anti-cancer properties—though the authors caution against taking melatonin supplements for prevention without medical advice until mechanisms are better understood, and emphasize the need for high-quality research accounting for environmental confounding factors to clarify the role of light pollution in breast cancer development.
2020
Int J Mol Sci
The gut microbiome—trillions of bacteria living in the digestive tract—appears to influence breast cancer risk, treatment effectiveness, and likelihood of recurrence through its effects on metabolism, hormones, immune function, and brain signaling. While cancer treatments can disrupt the gut microbiome and contribute to negative side effects, research shows that the microbiome can be positively modified through diet, probiotic and prebiotic supplements, and exercise. This review synthesizes current evidence on the gut-breast cancer connection and highlights practical strategies for improving gut health that may lead to better treatment outcomes, fewer side effects, and improved overall wellbeing for breast cancer patients.
2020
PLOS One
A matched case-control study in Karachi, Pakistan examined 411 women with newly diagnosed breast cancer and 784 cancer-free controls to investigate the relationship between Vitamin D levels, supplementation, sun exposure, and breast cancer risk in a population where both Vitamin D deficiency and breast cancer are prevalent. The study found that women with Vitamin D deficiency (serum levels <20 ng/ml) had a 65% increased risk of breast cancer compared to those with sufficient levels (>30 ng/ml), while women who took Vitamin D supplements in the year prior had a 68% reduced risk of breast cancer. The researchers conclude that Vitamin D deficiency is associated with increased breast cancer risk in Pakistani women, and suggest that maintaining adequate Vitamin D levels through supplementation could be a safe, affordable prevention strategy. This approach may be particularly beneficial for reducing breast cancer incidence and mortality among economically disadvantaged women in Pakistan who face barriers to early detection and treatment, though further research is needed to confirm these findings.
2019
Sci Rep
A case-control study of 1,050 breast cancer cases and 1,229 controls in which inflammatory markers (C-reactive protein and interleukin-6) were measured in 322 randomly selected case-control pairs examined whether dietary magnesium intake affects breast cancer risk directly and indirectly through inflammation. Higher magnesium intake was associated with 20% lower breast cancer risk (adjusted OR = 0.80; 95% CI: 0.65-0.99), while elevated CRP levels were associated with 43% increased risk (adjusted OR = 1.43; 95% CI: 1.02-2.01), though IL-6 showed no association with breast cancer. Path analysis revealed that dietary magnesium intake reduces breast cancer risk through two pathways: a direct protective effect and an indirect effect by lowering CRP levels, an inflammatory marker. These findings suggest that magnesium’s protective role against breast cancer operates both through anti-inflammatory mechanisms (by reducing systemic inflammation as measured by CRP) and through other direct biological pathways, highlighting the potential importance of adequate dietary magnesium intake for breast cancer prevention and the role of chronic inflammation in breast cancer development.
2019
Eur J Clinic Nutr
A meta-analysis of 23 prospective studies including 41,516 breast cancer cases and 1,171,048 individuals found that higher folate intake was associated with reduced risk of ER-/PR- breast cancer (RR = 0.82; 95% CI: 0.68-0.97), with each 100 μg/day increment decreasing risk by 6% for ER- and 10% for ER-/PR- subtypes. Additionally, high folate intake showed protective effects in premenopausal women (RR = 0.94) and individuals with moderate-to-high alcohol consumption (RR = 0.82), suggesting folate may be particularly beneficial for hormone receptor-negative breast cancers and specific high-risk populations.
2025
Environ Res
A study analyzing 156 commercially available prenatal vitamins, 19 folate/folic acid supplements, and 9 prescription prenatals found widespread contamination with heavy metals and phthalates: 83% of commercial prenatals contained detectable lead (15% exceeding California’s 0.5 μg/daily threshold), 73% contained cadmium, 25% contained DEHP, and 13% contained DBP, with higher contamination associated with calcium and iron content and caplet/capsule/tablet formulations. Prescription prenatals also showed contamination, with 7 of 9 containing detectable lead or cadmium and 33% exceeding the lead threshold, while folate/folic acid supplements showed lower contamination levels. These findings reveal that pregnant women—a population particularly vulnerable to environmental chemical exposures—are being exposed to lead, cadmium, and endocrine-disrupting phthalates through the very supplements intended to support healthy pregnancy. Since prenatal supplementation remains critical for fetal development, pregnant women should prioritize products with third-party verification seals (such as USP, NSF International, or ConsumerLab) which confirm label accuracy, purity, and manufacturing standards, and clear, enforceable regulations requiring frequent testing and strict contamination limits are urgently needed.